Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52


Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.

Maganto-García E, Tarrio ML, Grabie N, Bu DX, Lichtman AH.

Circulation. 2011 Jul 12;124(2):185-95. doi: 10.1161/CIRCULATIONAHA.110.006411. Epub 2011 Jun 20.


Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function.

Housley WJ, Adams CO, Nichols FC, Puddington L, Lingenheld EG, Zhu L, Rajan TV, Clark RB.

J Immunol. 2011 Jun 15;186(12):6779-87. doi: 10.4049/jimmunol.1003868. Epub 2011 May 13.


Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.

Zhou CC, Irani RA, Zhang Y, Blackwell SC, Mi T, Wen J, Shelat H, Geng YJ, Ramin SM, Kellems RE, Xia Y.

Circulation. 2010 Jan 26;121(3):436-44. doi: 10.1161/CIRCULATIONAHA.109.902890. Epub 2010 Jan 11.


Regulatory T cells in transplantation: transferring mouse studies to the clinic.

Long E, Wood KJ.

Transplantation. 2009 Nov 15;88(9):1050-6. doi: 10.1097/TP.0b013e3181bb7913. Review.


CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, Pipeling MR, Brower RG, Tuder RM, McDyer JF, King LS.

J Clin Invest. 2009 Oct;119(10):2898-913. doi: 10.1172/JCI36498. Epub 2009 Sep 21.


Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines.

Nolting J, Daniel C, Reuter S, Stuelten C, Li P, Sucov H, Kim BG, Letterio JJ, Kretschmer K, Kim HJ, von Boehmer H.

J Exp Med. 2009 Sep 28;206(10):2131-9. doi: 10.1084/jem.20090639. Epub 2009 Sep 8.


Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

Curotto de Lafaille MA, Lafaille JJ.

Immunity. 2009 May;30(5):626-35. doi: 10.1016/j.immuni.2009.05.002. Review.


Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Zhang N, Schröppel B, Lal G, Jakubzick C, Mao X, Chen D, Yin N, Jessberger R, Ochando JC, Ding Y, Bromberg JS.

Immunity. 2009 Mar 20;30(3):458-69. doi: 10.1016/j.immuni.2008.12.022.


Regulatory lymphocytes and intestinal inflammation.

Izcue A, Coombes JL, Powrie F.

Annu Rev Immunol. 2009;27:313-38. doi: 10.1146/annurev.immunol.021908.132657. Review.


Expansion of human regulatory T-cells from patients with type 1 diabetes.

Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA.

Diabetes. 2009 Mar;58(3):652-62. doi: 10.2337/db08-1168. Epub 2008 Dec 15.


Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.

Hill JA, Hall JA, Sun CM, Cai Q, Ghyselinck N, Chambon P, Belkaid Y, Mathis D, Benoist C.

Immunity. 2008 Nov 14;29(5):758-70. doi: 10.1016/j.immuni.2008.09.018.


Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.

Lee NY, Ray B, How T, Blobe GC.

J Biol Chem. 2008 Nov 21;283(47):32527-33. doi: 10.1074/jbc.M803059200. Epub 2008 Sep 5.


Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.

Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ.

Immunity. 2008 Jul 18;29(1):114-26. doi: 10.1016/j.immuni.2008.05.010.


Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators.

van Mierlo GJ, Scherer HU, Hameetman M, Morgan ME, Flierman R, Huizinga TW, Toes RE.

J Immunol. 2008 Mar 1;180(5):2747-51.


All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.

Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ.

J Exp Med. 2007 Aug 6;204(8):1765-74. Epub 2007 Jul 9.


Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H.

Science. 2007 Jul 13;317(5835):256-60. Epub 2007 Jun 14.


The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo.

Alcaide P, King SL, Dimitroff CJ, Lim YC, Fuhlbrigge RC, Luscinskas FW.

J Invest Dermatol. 2007 Aug;127(8):1964-72. Epub 2007 Mar 29.


Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

Bierie B, Moses HL.

Nat Rev Cancer. 2006 Jul;6(7):506-20. Review.


Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.

Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE.

Circulation. 2006 May 16;113(19):2301-12. Epub 2006 May 8.

Items per page

Supplemental Content

Write to the Help Desk